Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
APNmAb005 RAA7 Alzheimer's Disease (Phase 1) Aprinoia Therapeutics Tau Immunotherapy (passive)
ASN51 ASN121151 Alzheimer's Disease (Phase 1) Asceneuron SA Tau Small Molecule
BIIB080 IONIS-MAPTRx,
ISIS 814907
Alzheimer's Disease (Phase 1) Biogen, IONIS Pharmaceuticals Tau DNA/RNA-based
BIIB113 Alzheimer's Disease (Phase 1) Biogen Tau Small Molecule
BMS-986446 PRX005 Alzheimer's Disease (Phase 1) Bristol-Myers Squibb, Prothena Tau Immunotherapy (passive)
Efavirenz Efavirenz Alzheimer's Disease (Phase 1) Amyloid-Related, Tau, Cholesterol Small Molecule HIV infection
Lu AF87908 hC10.2 Alzheimer's Disease (Phase 1) Lundbeck Tau Immunotherapy (passive)
MK-2214 Alzheimer's Disease (Phase 1) Merck Tau Immunotherapy (passive)
NIO752 Progressive Supranuclear Palsy (Phase 1), Alzheimer's Disease (Phase 1) Novartis Pharmaceuticals Corporation Tau DNA/RNA-based
OLX-07010 Alzheimer's Disease (Phase 1) Oligomerix, Inc. Tau Small Molecule
PNT001 Alzheimer's Disease (Phase 1), Traumatic Brain Injury (Phase 1) Pinteon Therapeutics Tau Immunotherapy (passive)